US

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Republic of Korea *

all-in-one-crispr1920x640

Literature - Publication Review

All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells

Discover how scientists from TaiRx Inc. and Revvity preclinical services teamed up to explore efficacy improvements for a novel anti-cancer drug in our literature review.

In this literature, you will:

Find out how CRISPR screening can be used to identify key genes and pathways of importance
Learn how the team’s approach was applied to identify robust, actionable hits
See data from a deeper dive analysis into the mTOR pathway

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

Have a sales representative contact me

First Name

Last Name

Country

Email Address

Company

Zip / Postal Code

Business Phone

Role

Products and Services of Interest

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

Download Resource

All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells

Download Literature - Publication Review